|
시장보고서
상품코드
1457951
세계의 외과 수술 시장 : 시장 규모, 점유율 분석, 산업 수요 예측(-2030년)Surgical Procedures Market Size and Share Analysis by Type, Provider, Gender, Age Group - Global Industry Demand Forecast to 2030 |
||||||
세계의 외과 수술(Surgical Procedures) 시장은 2023년에 1억 1,000만 건이었으며, 2030년에 1억 3,750만 건으로 달할 것으로 예상되며, 3.3%의 CAGR로 추이하며 확대 될 것으로 예상됩니다.
이 주된 이유는 만성 질환, 특히 암과 CVD의 발병률이 급증하고 노인 인구가 증가하는 것과 관련이 있습니다.
시장을 선도하는 북미
2023년 시장 점유율은 북미가 50%로 최대였습니다. 이는 심장 질환, 정형외과 질환, 소화기 질환과 같은 질병의 이환율이 증가함에 따라 발달된 의료 제도가 존재하기 때문입니다.
아시아 태평양은 향후 수년간 약 3.5%의 가장 빠른 속도로 성장할 것입니다. 이는 만성질환에 대한 의식의 고조, 개발된 수술기술의 등장, 신경질환과 외상 발생률 증가, 의료·메디컬 투어리즘 부문의 융성 등이 배경에 있습니다.
부문별 통찰
2023년에는 산부인과 카테고리가 약 30%의 점유율을 차지하고 최대 점유율을 차지했습니다. 이는 다낭성 난소증후군(PCOS), 자궁내막증, 난소낭종, 만성골반통, 난소·자궁암, 골반내염증성 질환, 자궁근종, 자궁선근증 등 부인과 질환의 발생 비율이 증가하고 있기 때문입니다.
한편 안과 영역은 향후 수년간 약 3.7%라는 가장 빠른 속도로 진보할 것으로 보입니다. 이는 주로 녹내장, 당뇨병성 망막증, 백내장 등 다양한 안과 질환의 발생이 증가하고 있기 때문입니다.
2023년에는 병원이 약 45%의 점유율에서 가장 큰 최종 사용자 범주이며 지난 10년 동안 최대로 지속될 것으로 보입니다. 이는 전 세계적으로 이러한 의료 환경에서 실시되는 수술 건수가 많고 다양한 만성 질환의 유병률이 상승하고 있는 것에 근거합니다.
세계의 외과 수술(Surgical Procedures) 시장을 분석했으며, 시장의 기본 구조/최신 상황/주요 촉진 및 억제 요인/전 세계 및 지역별 및 주요 국가 시장 규모 동향 전망(건수, 금액 기준, 2017-2030년)/유형별·제공업체별·남녀별·연령층별 상세 동향/현재 시장 경쟁 상황/주요 기업 프로파일 등 정보를 전해드립니다.
목차
제1장 조사 범위
제2장 조사 방법
제3장 주요 요약
제4장 시장 지표
제5장 산업 전망
- 시장 역학
- 동향
- 성장 촉진 요인
- 억제 요인/과제
- 성장 촉진 요인/억제 요인의 영향 분석
- COVID-19의 영향
- Porter's Five Forces 분석
제6장 시장
- 개요
- 시장 규모 : 유형별(2017-2030년)
- 시장 매출 : 유형별(2017-2030년)
- 시장 규모 : 제공업체별(2017-2030년)
- 시장 매출 : 제공업체별(2017-2030년)
- 시장 규모 : 남녀별(2017-2030년)
- 시장 매출 : 남녀별(2017-2030년)
- 시장 규모 : 연령층별(2017-2030년)
- 시장 매출 : 연령층별(2017-2030년)
- 시장 규모 : 지역별(2017-2030년)
- 시장 매출 : 지역별(2017-2030년)
제7장 북미 시장
- 개요
- 시장 규모 : 유형별(2017-2030년)
- 시장 매출 : 유형별(2017-2030년)
- 시장 규모 : 제공업체별(2017-2030년)
- 시장 매출 : 제공업체별(2017-2030년)
- 시장 규모 : 남녀별(2017-2030년)
- 시장 매출 : 남녀별(2017-2030년)
- 시장 규모 : 연령층별(2017-2030년)
- 시장 매출 : 연령층별(2017-2030년)
- 시장 규모 : 국가별(2017-2030년)
- 시장 매출 : 국가별(2017-2030년)
제8장 유럽 시장
제9장 아시아 태평양 시장
제10장 남미 시장
제11장 중동 및 아프리카(MEA) 시장
제12장 미국 시장
- 개요
- 시장 규모 : 유형별(2017-2030년)
- 시장 매출 : 유형별(2017-2030년)
- 시장 규모 : 제공업체별(2017-2030년)
- 시장 매출 : 제공업체별(2017-2030년)
- 시장 규모 : 남녀별(2017-2030년)
- 시장 매출 : 남녀별(2017-2030년)
- 시장 규모 : 연령층별(2017-2030년)
- 시장 매출 : 연령층별(2017-2030년)
제13장 캐나다 시장
제14장 독일 시장
제15장 프랑스 시장
제16장 영국 시장
제17장 이탈리아 시장
제18장 스페인 시장
제19장 일본 시장
제20장 중국 시장
제21장 인도 시장
제22장 호주 시장
제23장 한국시장
제24장 브라질 시장
제25장 멕시코 시장
제26장 사우디아라비아 시장
제27장 남아프리카 시장
제28장 아랍에미리트(UAE) 시장
제29장 경쟁 구도
- 시장 진출기업 및 제공 제품 및 서비스 목록
- 주요 기업의 경쟁 벤치마킹
- 주요 기업의 제품 벤치마킹
- 최근의 전략 전개 상황
제30장 기업 프로파일
- Stryker Corporation
- Becton, Dickinson and Company
- Olympus Corporation
- Zimmer Biomet
- Abbott Laboratories
- Boston Scientific Corporation
- Smith&Nephew
- Medtronic plc
- Cook Medical
- CONMED Corporation
제31장 부록
LYJ 24.04.18The surgical procedures market was 110.0 million procedures in 2023, and it will increase to 137.5 million, advancing at a 3.3% compound annual growth rate, by 2030.
This is mainly because of the surging incidence of chronic disorders, particularly cancer and CVDs; coupled with the increasing elderly population.
Aging people are more vulnerable to chronic ailments like diabetes, cancer, cardiovascular diseases, and neurological disorders, which led to the growing need for surgical procedures. Likewise, the low levels of immunity make the elderly population more susceptible to infections, therefore resulting in an increase in the number of surgical procedures.
As per the World Health Organization, there were an estimated 20 million new cases of cancer and 9.7 million deaths in 2022.
The projected number of individuals who were alive within 5 years following a cancer diagnosis was 53.5 million.
Approximately 1 out of 5 people develop cancer in their lifetime, around 1 out of 12 women and 1 out of 9 men die from the ailment.
Moreover, as per a report, worldwide death counts because of CVD increase to 19.8 million in 2022 from 12.4 million in 1990 reflecting worldwide population growth as well as aging.
Furthermore, the technological improvements in the surgical process will further assist the growth of this industry in the years to come.
The high count of outpatient surgeries is offering significant growth opportunities to the industry. Outpatient surgeries do not mandate an overnight stay at the hospital. Currently, medical procedures are increasing at outpatient facilities due to technological improvements, counting the arrival of minimally invasive surgeries, and the accessibility of value-based care incentives.
North America is Leading Market
North America accounted for the largest share of the industry in 2023, of 50%. This is because of the existence of developed healthcare systems, along with the rising incidence of diseases like cardiac, orthopedic, and gastrointestinal disorders.
Moreover, the higher acceptance rate of cutting-edge devices as well as the change in the fondness toward outpatient surgeries are also aiding the regional industry growth.
APAC will advance at the fastest rate of approximately 3.5% in the coming years. This is because of the rising consciousness of chronic disorders, the arrival of developed surgical technologies, the increasing incidence of neurological disorders and traumatic injuries, and the flourishing healthcare and medical tourism sectors, in this region.
Segmentation Insights
The obstetric & gynecological category was the largest contributor to the industry in 2023, with approximately 30% share. This is ascribed to the increasing incidence of gynecological disorders, including polycystic ovary syndrome (PCOS), endometriosis, ovarian cysts, chronic pelvic pain, ovarian and uterine cancer, pelvic inflammatory disease, uterine fibroids, and adenomyosis.
Whereas, the ophthalmic category will advance at the fastest rate, of approximately 3.7%, in the years to come. This can be mainly because of the increasing occurrence of various ophthalmic disorders, such as glaucoma, diabetic retinopathy, and cataracts.
The hospital was the largest end user category in 2023, with approximately 45% share, and it will remain the largest throughout this decade. This is because of the high count of surgeries carried out in these healthcare settings globally; and the rising prevalence of various chronic ailments.
With the surging occurrence of chronic diseases across the globe, the need for surgical procedures will continue to increase in the years to come.
Table of Contents
Chapter 1. Research Scope
- 1.1. Research Objectives
- 1.2. Market Definition
- 1.3. Analysis Period
- 1.4. Market Size Breakdown by Segments
- 1.4.1. Market size breakdown, by type
- 1.4.2. Market size breakdown, by provider
- 1.4.3. Market size breakdown, by gender
- 1.4.4. Market size breakdown, by age group
- 1.4.5. Market size breakdown, by region
- 1.4.6. Market size breakdown, by country
- 1.5. Market Data Reporting Unit
- 1.5.1. Volume
- 1.5.2. Value
- 1.6. Key Stakeholders
Chapter 2. Research Methodology
- 2.1. Secondary Research
- 2.1.1. Paid
- 2.1.2. Unpaid
- 2.1.3. P&S Intelligence database
- 2.2. Primary Research
- 2.3. Market Size Estimation
- 2.4. Data Triangulation
- 2.5. Currency Conversion Rates
- 2.6. Assumptions for the Study
- 2.7. Notes and Caveats
Chapter 3. Executive Summary
Chapter 4. Market Indicators
Chapter 5. Industry Outlook
- 5.1. Market Dynamics
- 5.1.1. Trends
- 5.1.2. Drivers
- 5.1.3. Restraints/challenges
- 5.1.4. Impact analysis of drivers/restraints
- 5.2. Impact of COVID-19
- 5.3. Porter's Five Forces Analysis
- 5.3.1. Bargaining power of buyers
- 5.3.2. Bargaining power of suppliers
- 5.3.3. Threat of new entrants
- 5.3.4. Intensity of rivalry
- 5.3.5. Threat of substitutes
Chapter 6. Global Market
- 6.1. Overview
- 6.2. Market Volume, by Type (2017-2030)
- 6.3. Market Revenue, by Type (2017-2030)
- 6.4. Market Volume, by Provider (2017-2030)
- 6.5. Market Revenue, by Provider (2017-2030)
- 6.6. Market Volume, by Gender (2017-2030)
- 6.7. Market Revenue, by Gender (2017-2030)
- 6.8. Market Volume, by Age Group (2017-2030)
- 6.9. Market Revenue, by Age Group (2017-2030)
- 6.10. Market Volume, by Region (2017-2030)
- 6.11. Market Revenue, by Region (2017-2030)
Chapter 7. North America Market
- 7.1. Overview
- 7.2. Market Volume, by Type (2017-2030)
- 7.3. Market Revenue, by Type (2017-2030)
- 7.4. Market Volume, by Provider (2017-2030)
- 7.5. Market Revenue, by Provider (2017-2030)
- 7.6. Market Volume, by Gender (2017-2030)
- 7.7. Market Revenue, by Gender (2017-2030)
- 7.8. Market Volume, by Age Group (2017-2030)
- 7.9. Market Revenue, by Age Group (2017-2030)
- 7.10. Market Volume, by Country (2017-2030)
- 7.11. Market Revenue, by Country (2017-2030)
Chapter 8. Europe Market
- 8.1. Overview
- 8.2. Market Volume, by Type (2017-2030)
- 8.3. Market Revenue, by Type (2017-2030)
- 8.4. Market Volume, by Provider (2017-2030)
- 8.5. Market Revenue, by Provider (2017-2030)
- 8.6. Market Volume, by Gender (2017-2030)
- 8.7. Market Revenue, by Gender (2017-2030)
- 8.8. Market Volume, by Age Group (2017-2030)
- 8.9. Market Revenue, by Age Group (2017-2030)
- 8.10. Market Volume, by Country (2017-2030)
- 8.11. Market Revenue, by Country (2017-2030)
Chapter 9. APAC Market
- 9.1. Overview
- 9.2. Market Volume, by Type (2017-2030)
- 9.3. Market Revenue, by Type (2017-2030)
- 9.4. Market Volume, by Provider (2017-2030)
- 9.5. Market Revenue, by Provider (2017-2030)
- 9.6. Market Volume, by Gender (2017-2030)
- 9.7. Market Revenue, by Gender (2017-2030)
- 9.8. Market Volume, by Age Group (2017-2030)
- 9.9. Market Revenue, by Age Group (2017-2030)
- 9.10. Market Volume, by Country (2017-2030)
- 9.11. Market Revenue, by Country (2017-2030)
Chapter 10. LATAM Market
- 10.1. Overview
- 10.2. Market Volume, by Type (2017-2030)
- 10.3. Market Revenue, by Type (2017-2030)
- 10.4. Market Volume, by Provider (2017-2030)
- 10.5. Market Revenue, by Provider (2017-2030)
- 10.6. Market Volume, by Gender (2017-2030)
- 10.7. Market Revenue, by Gender (2017-2030)
- 10.8. Market Volume, by Age Group (2017-2030)
- 10.9. Market Revenue, by Age Group (2017-2030)
- 10.10. Market Volume, by Country (2017-2030)
- 10.11. Market Revenue, by Country (2017-2030)
Chapter 11. MEA Market
- 11.1. Overview
- 11.2. Market Volume, by Type (2017-2030)
- 11.3. Market Revenue, by Type (2017-2030)
- 11.4. Market Volume, by Provider (2017-2030)
- 11.5. Market Revenue, by Provider (2017-2030)
- 11.6. Market Volume, by Gender (2017-2030)
- 11.7. Market Revenue, by Gender (2017-2030)
- 11.8. Market Volume, by Age Group (2017-2030)
- 11.9. Market Revenue, by Age Group (2017-2030)
- 11.10. Market Volume, by Country (2017-2030)
- 11.11. Market Revenue, by Country (2017-2030)
Chapter 12. U.S. Market
- 12.1. Overview
- 12.2. Market Volume, by Type (2017-2030)
- 12.3. Market Revenue, by Type (2017-2030)
- 12.4. Market Volume, by Provider (2017-2030)
- 12.5. Market Revenue, by Provider (2017-2030)
- 12.6. Market Volume, by Gender (2017-2030)
- 12.7. Market Revenue, by Gender (2017-2030)
- 12.8. Market Volume, by Age Group (2017-2030)
- 12.9. Market Revenue, by Age Group (2017-2030)
Chapter 13. Canada Market
- 13.1. Overview
- 13.2. Market Volume, by Type (2017-2030)
- 13.3. Market Revenue, by Type (2017-2030)
- 13.4. Market Volume, by Provider (2017-2030)
- 13.5. Market Revenue, by Provider (2017-2030)
- 13.6. Market Volume, by Gender (2017-2030)
- 13.7. Market Revenue, by Gender (2017-2030)
- 13.8. Market Volume, by Age Group (2017-2030)
- 13.9. Market Revenue, by Age Group (2017-2030)
Chapter 14. Germany Market
- 14.1. Overview
- 14.2. Market Volume, by Type (2017-2030)
- 14.3. Market Revenue, by Type (2017-2030)
- 14.4. Market Volume, by Provider (2017-2030)
- 14.5. Market Revenue, by Provider (2017-2030)
- 14.6. Market Volume, by Gender (2017-2030)
- 14.7. Market Revenue, by Gender (2017-2030)
- 14.8. Market Volume, by Age Group (2017-2030)
- 14.9. Market Revenue, by Age Group (2017-2030)
Chapter 15. France Market
- 15.1. Overview
- 15.2. Market Volume, by Type (2017-2030)
- 15.3. Market Revenue, by Type (2017-2030)
- 15.4. Market Volume, by Provider (2017-2030)
- 15.5. Market Revenue, by Provider (2017-2030)
- 15.6. Market Volume, by Gender (2017-2030)
- 15.7. Market Revenue, by Gender (2017-2030)
- 15.8. Market Volume, by Age Group (2017-2030)
- 15.9. Market Revenue, by Age Group (2017-2030)
Chapter 16. U.K. Market
- 16.1. Overview
- 16.2. Market Volume, by Type (2017-2030)
- 16.3. Market Revenue, by Type (2017-2030)
- 16.4. Market Volume, by Provider (2017-2030)
- 16.5. Market Revenue, by Provider (2017-2030)
- 16.6. Market Volume, by Gender (2017-2030)
- 16.7. Market Revenue, by Gender (2017-2030)
- 16.8. Market Volume, by Age Group (2017-2030)
- 16.9. Market Revenue, by Age Group (2017-2030)
Chapter 17. Italy Market
- 17.1. Overview
- 17.2. Market Volume, by Type (2017-2030)
- 17.3. Market Revenue, by Type (2017-2030)
- 17.4. Market Volume, by Provider (2017-2030)
- 17.5. Market Revenue, by Provider (2017-2030)
- 17.6. Market Volume, by Gender (2017-2030)
- 17.7. Market Revenue, by Gender (2017-2030)
- 17.8. Market Volume, by Age Group (2017-2030)
- 17.9. Market Revenue, by Age Group (2017-2030)
Chapter 18. Spain Market
- 18.1. Overview
- 18.2. Market Volume, by Type (2017-2030)
- 18.3. Market Revenue, by Type (2017-2030)
- 18.4. Market Volume, by Provider (2017-2030)
- 18.5. Market Revenue, by Provider (2017-2030)
- 18.6. Market Volume, by Gender (2017-2030)
- 18.7. Market Revenue, by Gender (2017-2030)
- 18.8. Market Volume, by Age Group (2017-2030)
- 18.9. Market Revenue, by Age Group (2017-2030)
Chapter 19. Japan Market
- 19.1. Overview
- 19.2. Market Volume, by Type (2017-2030)
- 19.3. Market Revenue, by Type (2017-2030)
- 19.4. Market Volume, by Provider (2017-2030)
- 19.5. Market Revenue, by Provider (2017-2030)
- 19.6. Market Volume, by Gender (2017-2030)
- 19.7. Market Revenue, by Gender (2017-2030)
- 19.8. Market Volume, by Age Group (2017-2030)
- 19.9. Market Revenue, by Age Group (2017-2030)
Chapter 20. China Market
- 20.1. Overview
- 20.2. Market Volume, by Type (2017-2030)
- 20.3. Market Revenue, by Type (2017-2030)
- 20.4. Market Volume, by Provider (2017-2030)
- 20.5. Market Revenue, by Provider (2017-2030)
- 20.6. Market Volume, by Gender (2017-2030)
- 20.7. Market Revenue, by Gender (2017-2030)
- 20.8. Market Volume, by Age Group (2017-2030)
- 20.9. Market Revenue, by Age Group (2017-2030)
Chapter 21. India Market
- 21.1. Overview
- 21.2. Market Volume, by Type (2017-2030)
- 21.3. Market Revenue, by Type (2017-2030)
- 21.4. Market Volume, by Provider (2017-2030)
- 21.5. Market Revenue, by Provider (2017-2030)
- 21.6. Market Volume, by Gender (2017-2030)
- 21.7. Market Revenue, by Gender (2017-2030)
- 21.8. Market Volume, by Age Group (2017-2030)
- 21.9. Market Revenue, by Age Group (2017-2030)
Chapter 22. Australia Market
- 22.1. Overview
- 22.2. Market Volume, by Type (2017-2030)
- 22.3. Market Revenue, by Type (2017-2030)
- 22.4. Market Volume, by Provider (2017-2030)
- 22.5. Market Revenue, by Provider (2017-2030)
- 22.6. Market Volume, by Gender (2017-2030)
- 22.7. Market Revenue, by Gender (2017-2030)
- 22.8. Market Volume, by Age Group (2017-2030)
- 22.9. Market Revenue, by Age Group (2017-2030)
Chapter 23. South Korea Market
- 23.1. Overview
- 23.2. Market Volume, by Type (2017-2030)
- 23.3. Market Revenue, by Type (2017-2030)
- 23.4. Market Volume, by Provider (2017-2030)
- 23.5. Market Revenue, by Provider (2017-2030)
- 23.6. Market Volume, by Gender (2017-2030)
- 23.7. Market Revenue, by Gender (2017-2030)
- 23.8. Market Volume, by Age Group (2017-2030)
- 23.9. Market Revenue, by Age Group (2017-2030)
Chapter 24. Brazil Market
- 24.1. Overview
- 24.2. Market Volume, by Type (2017-2030)
- 24.3. Market Revenue, by Type (2017-2030)
- 24.4. Market Volume, by Provider (2017-2030)
- 24.5. Market Revenue, by Provider (2017-2030)
- 24.6. Market Volume, by Gender (2017-2030)
- 24.7. Market Revenue, by Gender (2017-2030)
- 24.8. Market Volume, by Age Group (2017-2030)
- 24.9. Market Revenue, by Age Group (2017-2030)
Chapter 25. Mexico Market
- 25.1. Overview
- 25.2. Market Volume, by Type (2017-2030)
- 25.3. Market Revenue, by Type (2017-2030)
- 25.4. Market Volume, by Provider (2017-2030)
- 25.5. Market Revenue, by Provider (2017-2030)
- 25.6. Market Volume, by Gender (2017-2030)
- 25.7. Market Revenue, by Gender (2017-2030)
- 25.8. Market Volume, by Age Group (2017-2030)
- 25.9. Market Revenue, by Age Group (2017-2030)
Chapter 26. Saudi Arabia Market
- 26.1. Overview
- 26.2. Market Volume, by Type (2017-2030)
- 26.3. Market Revenue, by Type (2017-2030)
- 26.4. Market Volume, by Provider (2017-2030)
- 26.5. Market Revenue, by Provider (2017-2030)
- 26.6. Market Volume, by Gender (2017-2030)
- 26.7. Market Revenue, by Gender (2017-2030)
- 26.8. Market Volume, by Age Group (2017-2030)
- 26.9. Market Revenue, by Age Group (2017-2030)
Chapter 27. South Africa Market
- 27.1. Overview
- 27.2. Market Volume, by Type (2017-2030)
- 27.3. Market Revenue, by Type (2017-2030)
- 27.4. Market Volume, by Provider (2017-2030)
- 27.5. Market Revenue, by Provider (2017-2030)
- 27.6. Market Volume, by Gender (2017-2030)
- 27.7. Market Revenue, by Gender (2017-2030)
- 27.8. Market Volume, by Age Group (2017-2030)
- 27.9. Market Revenue, by Age Group (2017-2030)
Chapter 28. U.A.E. Market
- 28.1. Overview
- 28.2. Market Volume, by Type (2017-2030)
- 28.3. Market Revenue, by Type (2017-2030)
- 28.4. Market Volume, by Provider (2017-2030)
- 28.5. Market Revenue, by Provider (2017-2030)
- 28.6. Market Volume, by Gender (2017-2030)
- 28.7. Market Revenue, by Gender (2017-2030)
- 28.8. Market Volume, by Age Group (2017-2030)
- 28.9. Market Revenue, by Age Group (2017-2030)
Chapter 29. Competitive Landscape
- 29.1. List of Market Players and their Offerings
- 29.2. Competitive Benchmarking of Key Players
- 29.3. Product Benchmarking of Key Players
- 29.4. Recent Strategic Developments
Chapter 30. Company Profiles
- 30.1. Stryker Corporation
- 30.1.1. Business overview
- 30.1.2. Product and service offerings
- 30.1.3. Key financial summary
- 30.2. Becton, Dickinson and Company
- 30.2.1. Business overview
- 30.2.2. Product and service offerings
- 30.2.3. Key financial summary
- 30.3. Olympus Corporation
- 30.3.1. Business overview
- 30.3.2. Product and service offerings
- 30.3.3. Key financial summary
- 30.4. Zimmer Biomet
- 30.4.1. Business overview
- 30.4.2. Product and service offerings
- 30.4.3. Key financial summary
- 30.5. Abbott Laboratories
- 30.5.1. Business overview
- 30.5.2. Product and service offerings
- 30.5.3. Key financial summary
- 30.6. Boston Scientific Corporation
- 30.6.1. Business overview
- 30.6.2. Product and service offerings
- 30.6.3. Key financial summary
- 30.7. Smith & Nephew
- 30.7.1. Business overview
- 30.7.2. Product and service offerings
- 30.7.3. Key financial summary
- 30.8. Medtronic plc
- 30.8.1. Business overview
- 30.8.2. Product and service offerings
- 30.8.3. Key financial summary
- 30.9. Cook Medical
- 30.9.1. Business overview
- 30.9.2. Product and service offerings
- 30.9.3. Key financial summary
- 30.10. CONMED Corporation
- 30.10.1. Business overview
- 30.10.2. Product and service offerings
- 30.10.3. Key financial summary
Chapter 31. Appendix
- 31.1. Abbreviations
- 31.2. Sources and References
- 31.3. Related Reports
